250 related articles for article (PubMed ID: 11544479)
1. Gene polymorphism in Netherton and common atopic disease.
Walley AJ; Chavanas S; Moffatt MF; Esnouf RM; Ubhi B; Lawrence R; Wong K; Abecasis GR; Jones EY; Harper JI; Hovnanian A; Cookson WO
Nat Genet; 2001 Oct; 29(2):175-8. PubMed ID: 11544479
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese.
Nishio Y; Noguchi E; Shibasaki M; Kamioka M; Ichikawa E; Ichikawa K; Umebayashi Y; Otsuka F; Arinami T
Genes Immun; 2003 Oct; 4(7):515-7. PubMed ID: 14551605
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in SPINK5 are not associated with asthma in a Dutch population.
Jongepier H; Koppelman GH; Nolte IM; Bruinenberg M; Bleecker ER; Meyers DA; te Meerman GJ; Postma DS
J Allergy Clin Immunol; 2005 Mar; 115(3):486-92. PubMed ID: 15753894
[TBL] [Abstract][Full Text] [Related]
4. Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China.
Zhao LP; Di Z; Zhang L; Wang L; Ma L; Lv Y; Hong Y; Wei H; Chen HD; Gao XH
J Eur Acad Dermatol Venereol; 2012 May; 26(5):572-7. PubMed ID: 21585560
[TBL] [Abstract][Full Text] [Related]
5. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.
Chavanas S; Bodemer C; Rochat A; Hamel-Teillac D; Ali M; Irvine AD; Bonafé JL; Wilkinson J; Taïeb A; Barrandon Y; Harper JI; de Prost Y; Hovnanian A
Nat Genet; 2000 Jun; 25(2):141-2. PubMed ID: 10835624
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis.
Sprecher E; Chavanas S; DiGiovanna JJ; Amin S; Nielsen K; Prendiville JS; Silverman R; Esterly NB; Spraker MK; Guelig E; de Luna ML; Williams ML; Buehler B; Siegfried EC; Van Maldergem L; Pfendner E; Bale SJ; Uitto J; Hovnanian A; Richard G
J Invest Dermatol; 2001 Aug; 117(2):179-87. PubMed ID: 11511292
[TBL] [Abstract][Full Text] [Related]
7. Biochemical features, molecular biology and clinical relevance of the human 15-domain serine proteinase inhibitor LEKTI.
Walden M; Kreutzmann P; Drögemüller K; John H; Forssmann WG; Hans-Jürgen M
Biol Chem; 2002; 383(7-8):1139-41. PubMed ID: 12437098
[TBL] [Abstract][Full Text] [Related]
8. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6.
Egelrud T; Brattsand M; Kreutzmann P; Walden M; Vitzithum K; Marx UC; Forssmann WG; Mägert HJ
Br J Dermatol; 2005 Dec; 153(6):1200-3. PubMed ID: 16307658
[TBL] [Abstract][Full Text] [Related]
9. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population.
Kato A; Fukai K; Oiso N; Hosomi N; Murakami T; Ishii M
Br J Dermatol; 2003 Apr; 148(4):665-9. PubMed ID: 12752122
[TBL] [Abstract][Full Text] [Related]
10. LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome.
Ong C; O'Toole EA; Ghali L; Malone M; Smith VV; Callard R; Harper JI
Br J Dermatol; 2004 Dec; 151(6):1253-7. PubMed ID: 15606522
[TBL] [Abstract][Full Text] [Related]
11. The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.
Mägert HJ; Kreutzmann P; Drögemüller K; Ständker L; Adermann K; Walden M; John H; Korting HC; Forssmann WG
Eur J Med Res; 2002 Feb; 7(2):49-56. PubMed ID: 11891144
[TBL] [Abstract][Full Text] [Related]
12. Serine protease inhibitor lymphoepithelial Kazal type-related inhibitor tends to be decreased in atopic dermatitis.
Roedl D; Traidl-Hoffmann C; Ring J; Behrendt H; Braun-Falco M
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1263-6. PubMed ID: 19522716
[TBL] [Abstract][Full Text] [Related]
13. LEKTI domain 15 is a functional Kazal-type proteinase inhibitor.
Vitzithum K; Lauber T; Kreutzmann P; Schulz A; Sommerhoff CP; Rösch P; Marx UC
Protein Expr Purif; 2008 Jan; 57(1):45-56. PubMed ID: 17936012
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
[TBL] [Abstract][Full Text] [Related]
15. Netherton syndrome: report of two Taiwanese siblings with staphylococcal scalded skin syndrome and mutation of SPINK5.
Chao SC; Richard G; Lee JY
Br J Dermatol; 2005 Jan; 152(1):159-65. PubMed ID: 15656819
[TBL] [Abstract][Full Text] [Related]
16. A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins.
Di WL; Hennekam RC; Callard RE; Harper JI
Br J Dermatol; 2009 Aug; 161(2):404-12. PubMed ID: 19438860
[TBL] [Abstract][Full Text] [Related]
17. Rapid detection of the SPINK5 polymorphism Glu420Lys by real-time PCR technology.
Rihs HP; Kowal A; Raulf-Heimsoth M; Degens PO; Landt O; Brüning T
Clin Chim Acta; 2005 May; 355(1-2):185-9. PubMed ID: 15820494
[TBL] [Abstract][Full Text] [Related]
18. LEKTI-1 in sickness and in health.
Roelandt T; Thys B; Heughebaert C; De Vroede A; De Paepe K; Roseeuw D; Rombaut B; Hachem JP
Int J Cosmet Sci; 2009 Aug; 31(4):247-54. PubMed ID: 19467033
[TBL] [Abstract][Full Text] [Related]
19. Netherton syndrome: mutation analysis of two Taiwanese families.
Lin SP; Huang SY; Tu ME; Wu YH; Lin CY; Lin HY; Lee-Chen GJ
Arch Dermatol Res; 2007 Jun; 299(3):145-50. PubMed ID: 17415575
[TBL] [Abstract][Full Text] [Related]
20. Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor.
Kreutzmann P; Schulz A; Ständker L; Forssmann WG; Mägert HJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(1):75-81. PubMed ID: 15026000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
